4% Betaine Salicylate vs. 2% Salicylic Acid: Read the Label

VERACIL • EVIDENCE-FIRST SKINCARE

A bigger BHA percentage is not automatically a stronger treatment

Before comparing 4% with 2%, check whether the numbers refer to the same ingredient and whether the finished formulas were actually compared.

Use the percentage-check protocol

By The Veracil Research Team • Last updated: October 20, 2026

Medical disclaimer: Educational information, not a diagnosis or individualized acne-treatment plan. Persistent, painful, or scarring acne deserves clinical assessment. If you already use prescription treatment, ask your clinician before adding another active.

This page examines an online ingredient comparison. Current viral popularity has not been independently verified. Its focus is reading percentages across different salicylate ingredients, not a general exfoliation routine.

The specific label question

The retrieved description of COSRX BHA Blackhead Power Liquid Treatment lists 4% betaine salicylate, 2% niacinamide, and 68% white willow bark water. It does not describe the product as 4% salicylic acid. Those words matter.

This guide does not convert the betaine salicylate percentage into a supposedly equivalent salicylic acid percentage. No verified head-to-head finished-formula study reviewed here establishes such an equivalence or a predictable two-times-strength relationship.

What the clinical literature can, and cannot, supply

🟡 Tier 2: clinical-review context for salicylic acid, not this comparison

Bowe and Shalita (2008), Seminars in Cutaneous Medicine and Surgery, discuss salicylic acid as an over-the-counter acne ingredient with mild comedolytic and anti-inflammatory activity. Read the review, PMID 18786494.

This is ingredient-level clinical context, not a head-to-head trial of betaine salicylate and salicylic acid. It cannot rank the linked COSRX formula against an unspecified 2% salicylic acid product.

🟡 Tier 4: exact potency equivalence remains unconfirmed here

No controlled human comparison was verified here demonstrating that this 4% betaine salicylate formula produces the same acne outcome, irritation profile, or treatment strength as a particular 2% salicylic acid formula. The salicylic-acid discussion in Bowe and Shalita (2008), Seminars in Cutaneous Medicine and Surgery, PMID 18786494, does not fill that gap.

Why finished-product evidence matters

Decker and Graber (2012), The Journal of Clinical and Aesthetic Dermatology, note that many over-the-counter acne products lack well-controlled clinical studies and distinguish multiple delivery formats. Read the review, PMID 22808307. This is a methodological warning, not proof that every product lacks evidence. For the specific comparison here, ask what formula was tested rather than borrowing an ingredient's reputation.

What we verified about the COSRX listing

The catalog positions COSRX BHA Blackhead Power Liquid Treatment for mid-level acid users. It directs application after cleansing at the toner or essence step, initially two to three times weekly, with use adjusted according to skin condition. It also directs sunscreen use if applied during the day.

These are retrieved catalog directions, not a prescription for every reader. A complete current ingredient list, measured finished-product pH, and an independent head-to-head efficacy report were not verified here. Check the current packaging before use.

The listing's phrase about addressing blackheads “at once” should not be read as a clinically verified instant-result timeline. No finished-product trial reviewed here establishes immediate clearance or permanent pore-size change.

A percentage-check and routine protocol

This is a conservative product-selection framework, not a validated acne regimen.

Read the exact ingredient name. Record “betaine salicylate” rather than rewriting it as salicylic acid. Do the same for any product you compare.
Do not rank by the largest number. Ask for finished-formula evidence matching the outcome you want, not just a percentage comparison between differently named ingredients.
Check your current routine. If you already use an exfoliating active or prescription acne treatment, avoid automatically stacking a second product. Resolve compatibility with the appropriate clinician or manufacturer.
Follow the current label. For COSRX BHA Blackhead Power Liquid, verify the packaging directions rather than treating a search snippet or conversion chart as your regimen.
Change one product at a time. Keep other products stable so you can assess comfort and whether you like the routine.
Do not chase immediate clearance. No verified finished-product timeline was established here. Do not increase frequency to force an overnight result.
Stop if irritation develops. Burning or persistent redness should not be treated as proof of potency. Seek individualized advice for ongoing acne or an adverse reaction.

Shop This

Commercial disclosure: Veracil sells this product and earns revenue from purchases. The card identifies the exact catalog ingredient claim; it does not certify equivalence to a salicylic acid treatment or establish a clinical result for every user.

Shop This

COSRX BHA Blackhead Power Liquid Treatment

A leave-on format whose catalog lists 4% betaine salicylate and 2% niacinamide. That is not a verified claim of 4% salicylic acid or a documented equivalent to a particular 2% salicylic acid formula.

Shop Now

Questions before comparing bottles

Does this prove betaine salicylate does not work?

No. A missing verified equivalence comparison is not proof of ineffectiveness. It means this guide cannot support the specific numerical ranking.

Can willow bark percentage substitute for a salicylic acid percentage?

Do not relabel one ingredient claim as another. The listing separately identifies willow bark water and betaine salicylate; no verified conversion or finished-product assay was reviewed here.

Does the general salicylic acid literature validate this formula automatically?

No. Bowe and Shalita (2008), Seminars in Cutaneous Medicine and Surgery, PMID 18786494, offers context, not a trial of this product.

Calibrated verdict: Inconclusive for percentage-based equivalence

Salicylic acid has clinical-review support as an acne ingredient, as discussed by Bowe and Shalita (2008), Seminars in Cutaneous Medicine and Surgery, PMID 18786494. That does not establish that a 4% betaine salicylate label predicts twice the strength or the same results as a 2% salicylic acid product. Choose based on clear ingredient identity, current directions, and matching evidence, not the biggest number.